TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1102079

Group type: EXPERIMENTAL
Intervention: EMG feedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alpha feedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Joked control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All groups (including EMG, Alpha, and Joked control)
Number of subjects: 24
Study: 31837113

Group type: EXPERIMENTAL
Intervention: Lurasidone (40 or 80 mg/day)
Number of subjects: 281
Study: 30535188

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 27448178

Group type: EXPERIMENTAL
Intervention: Active listening taught as an attitude (6 students)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Active listening taught as a technique (6 students)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (7 students)
Number of subjects: 19
Study: 24651682

Group type: EXPERIMENTAL
Intervention: Lycopene intervention (29.4 mg of lycopene per day via 11.5 oz of V8 100% vegetable juice for 30 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lycopene intervention
Number of subjects: 40
Study: 22187385

Group type: EXPERIMENTAL
Intervention: 8‐Hz group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 26‐Hz group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Isometric group
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 8‐Hz and 26‐Hz groups
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Local vibrations (8Hz and 26Hz)
Number of subjects: 55
Study: 20156067

Group type: COMPARATOR
Intervention: Low-insulin step of the clamp in normal nonobese women
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-insulin step in normal nonobese women
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Clamp studies in obese PCOS women
Number of subjects: 8
Study: 18418126

Group type: COMPARATOR
Intervention: Detection of alpha1 integrin in urine using a double-sandwich enzyme-linked immunosorbent assay.
Number of subjects: 29
Study: 16011060

Group type: EXPERIMENTAL
Intervention: Balneotherapy (mud packs and sulfur pool) and exposure to the unique climatic conditions of the Dead Sea
Number of subjects: 28

Group type: COMPARATOR
Intervention: Climatotherapy (fresh water pool and same climatic conditions)
Number of subjects: 28
Study: 12039991

Group type: EXPERIMENTAL
Intervention: 200 mg/d sulodexide for 4 months
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 50 mg/d sulodexide for 4 months
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 100 mg/d sulodexide for 4 months
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 200 mg/d sulodexide at T8
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 10526897

Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: COMPARATOR
Intervention: 50 microg 17beta‐oestradiol transdermally (TTSE) per 24 h
Number of subjects: 60
Study: 7723978

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (normal saline injections)
Number of subjects: 10
Study: 2183405

Group type: EXPERIMENTAL
Intervention: Warfarin (prothrombin time of 1.3‐1.8 times control)
Number of subjects: 1644

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg/day)
Number of subjects: 1644

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1644
Study: 7058441

Group type: EXPERIMENTAL
Intervention: Active treatment with various therapeutic agents
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 31512573

Group type: EXPERIMENTAL
Intervention: Adolescent-led school intervention combining student-driven design and teacher-training component
Number of subjects: 7572

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 7572
Study: 29101128

Group type: EXPERIMENTAL
Intervention: PSORI‐CM01 granules (5.5 g, two times daily)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Yinxieling tablets (five tablets, three times daily)
Number of subjects: 556
Study: 25691622

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin at bedtime
Number of subjects: 290

Group type: COMPARATOR
Intervention: 100 mg aspirin on awakening
Number of subjects: 290
Study: 23759340

Group type: EXPERIMENTAL
Intervention: Osteopathic manual treatment (OMT)
Number of subjects: 455
Study: 21088598

Group type: EXPERIMENTAL
Intervention: TCI sufentanil (0.3 ng ml⁻¹)
Number of subjects: 100

Group type: COMPARATOR
Intervention: TCI remifentanil (3 ng ml⁻¹)
Number of subjects: 100
Study: 19701826

Group type: EXPERIMENTAL
Intervention: TITANOX stent
Number of subjects: 425

Group type: COMPARATOR
Intervention: PES
Number of subjects: 425
Study: 17192828

Group type: EXPERIMENTAL
Intervention: Colloid volume resuscitation (10% hydroxyethyl starch: 10% Hemohes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crystalloid volume resuscitation (Sterofundin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (Actrapid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional insulin therapy
Number of subjects: 0
Study: 16878328

Group type: EXPERIMENTAL
Intervention: EWS‐ATF1 fusion transcripts detection by real-time PCR analysis on paraffin embedded tissues
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: EWS‐ATF1 fusion transcripts detection in probable CCS samples
Number of subjects: 44

Group type: COMPARATOR
Intervention: EWS‐ATF1 transcripts detection in melanoma samples
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Mitotic index and histologic grade
Number of subjects: 44
Study: 12420156

Group type: EXPERIMENTAL
Intervention: Buspirone (10 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10813588

Group type: EXPERIMENTAL
Intervention: Oral glucose (30 g)
Number of subjects: 42
Study: 8665191

Group type: EXPERIMENTAL
Intervention: Single-dose ampicillin prophylaxis for hernia repair
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Single-dose ampicillin prophylaxis for ectopic pregnancy
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Single-dose ampicillin-metronidazole prophylaxis for hysterectomy
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Single-dose ampicillin-metronidazole prophylaxis for caesarean section
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Single-dose ampicillin prophylaxis with or without metronidazole
Number of subjects: 850

Group type: COMPARATOR
Intervention: Conventional postoperative penicillin therapy (control)
Number of subjects: 850
Study: 1516904

Group type: EXPERIMENTAL
Intervention: Thiothixene
Number of subjects: 6

Group type: COMPARATOR
Intervention: Oxazepam
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diphenhydramine
Number of subjects: 6
Study: 6384863

Group type: EXPERIMENTAL
Intervention: Continuous infusion of daily 0.5 X 10(6) IE fibroblast interferon/kg body weight for 3-5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31698177

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 99
Study: 28482746

Group type: EXPERIMENTAL
Intervention: NMES+PRO
Number of subjects: 20

Group type: COMPARATOR
Intervention: CON
Number of subjects: 20
Study: 25211285

Group type: EXPERIMENTAL
Intervention: CCaV at 120 CC per min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CCaV at 90 CC per min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3:1 C:V
Number of subjects: 30

Group type: COMPARATOR
Intervention: 3:1 C:V and CCaV
Number of subjects: 30
Study: 24639698

Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxy progesterone caproate (Femolife) injected intramuscularly every week until 36 weeks of gestation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo injected from 16 until 36 weeks of gestation
Number of subjects: 106
Study: 21275923

Group type: EXPERIMENTAL
Intervention: Weight-gain restriction program
Number of subjects: 155
Study: 18824331

Group type: EXPERIMENTAL
Intervention: SAM-e (800 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 16952543

Group type: EXPERIMENTAL
Intervention: Transanal irrigation
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conservative bowel management
Number of subjects: 87
Study: 15612864

Group type: EXPERIMENTAL
Intervention: Global Mood Scale (positive affect subscale)
Number of subjects: 786

Group type: COMPARATOR
Intervention: Other questionnaires (not specified)
Number of subjects: 786
Study: 11380742

Group type: EXPERIMENTAL
Intervention: Proactive geriatrics consultation
Number of subjects: 126

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 126
Study: 9412912

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine twice daily
Number of subjects: 43

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 43
Study: 8387940

Group type: EXPERIMENTAL
Intervention: Men consuming 10 g and 30 g of dietary fibre
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Women consuming 10 g and 30 g of dietary fibre
Number of subjects: 34
Study: 3540223

Group type: COMPARATOR
Intervention: Immediate-release (IR) verapamil (80 to 120 mg TID)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) verapamil (equivalent dose to IR)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Immediate-release (IR) verapamil
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) verapamil
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both IR and SR verapamil
Number of subjects: 8
Study: 30109784

Group type: EXPERIMENTAL
Intervention: Calcium-Polystyrene Sulfonate (Ca-PS) 3 × 5 g/day for 3 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (blank)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Calcium-Polystyrene Sulfonate (Ca-PS)
Number of subjects: 58
Study: 28073670

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) simulator training
Number of subjects: 17

Group type: COMPARATOR
Intervention: Benchtop (BT) simulator training
Number of subjects: 17
Study: 26308490

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 2 showers and a 1-minute pause before rinsing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 2 showers and a 2-minute pause before rinsing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 2 showers and no pause before rinsing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 3 showers and a 1-minute pause before rinsing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 3 showers and a 2-minute pause before rinsing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 3 showers and no pause before rinsing
Number of subjects: 120
Study: 23247745

Group type: EXPERIMENTAL
Intervention: Atorvastatin acid
Number of subjects: 20
Study: 21752665

Group type: EXPERIMENTAL
Intervention: Normothermia with intermittent warm blood cardioplegia (IWBC)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia (CCC)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups (IWBC and CCC)
Number of subjects: 47
Study: 18579440

Group type: EXPERIMENTAL
Intervention: Restrictive transmitral filling (RF) pattern (DT <= 140 ms)
Number of subjects: 972

Group type: COMPARATOR
Intervention: Non-restrictive transmitral filling (non-RF) pattern (DT > 140 ms)
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: Delayed relaxation (DT > 240 ms)
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: RF in patients with LVEF >= 50%
Number of subjects: 972
Study: 16472981

Group type: EXPERIMENTAL
Intervention: Perilla oil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Soybean oil
Number of subjects: 30
Study: 12620529

Group type: EXPERIMENTAL
Intervention: Apples
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Pears
Number of subjects: 411

Group type: COMPARATOR
Intervention: Oat cookies
Number of subjects: 411
Study: 12821234

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (median dose 120 microg four times a day)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 10813099

Group type: EXPERIMENTAL
Intervention: 50 micrograms of ethinyl estradiol (EE) and 1 mg of norethindrone (NET) from days 6 through 10 (Group I)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50 micrograms of ethinyl estradiol (EE) and 1 mg of norethindrone (NET) from days 8 through 12 (Group II)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both groups (I and II)
Number of subjects: 10
Study: 8880281

Group type: EXPERIMENTAL
Intervention: Protocol processing system (ProtoVIEW)
Number of subjects: 0
Study: 1649148

Group type: EXPERIMENTAL
Intervention: Local injection of beta‐IFN through an Ommaya reservoir
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: beta‐IFN followed by systemic chemotherapy (Cisplatin + Etoposide)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 28
Study: 6439234

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) administered as a dry powder via the spinhaler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30412077

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 0.8 μg/kg, pumped for over 10 minutes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (same volume pumped for 10 minutes)
Number of subjects: 0
Study: 26714803

Group type: EXPERIMENTAL
Intervention: Lidocaine with adrenaline
Number of subjects: 82

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 82
Study: 24460799

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 180

Group type: COMPARATOR
Intervention: Former and never smokers
Number of subjects: 180
Study: 21868590

Group type: EXPERIMENTAL
Intervention: Group visits conducted by 9 residents
Number of subjects: 7
Study: 19658043

Group type: EXPERIMENTAL
Intervention: 50 mg/day Zn as Zn sulfate
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 18042894

Group type: EXPERIMENTAL
Intervention: Paramedian approach (Group PM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midline approach (Group M)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 40
Study: 15848920

Group type: EXPERIMENTAL
Intervention: Traveling Vision Examiner (TVE) Program
Number of subjects: 239

Group type: COMPARATOR
Intervention: Local vision examiners
Number of subjects: 239
Study: 12153804

Group type: EXPERIMENTAL
Intervention: ERM peeling
Number of subjects: 91

Group type: COMPARATOR
Intervention: No ERM peeling
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Postoperative ERMs
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Preoperative hole size
Number of subjects: 91
Study: 9872200

Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NPPV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard medical therapy (ST)
Number of subjects: 30
Study: 8551652

Group type: EXPERIMENTAL
Intervention: Arginine aspartate (17 g free arginine)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 2164652

Group type: EXPERIMENTAL
Intervention: 50% trichloroacetic acid (single topical application)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Saline (placebo, single topical application)
Number of subjects: 34
Study: 626331

Group type: EXPERIMENTAL
Intervention: Spinal block in the lateral position combined with light sedation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard general anaesthetic
Number of subjects: 55
Study: 31172638

Group type: EXPERIMENTAL
Intervention: Provisional phase with soft tissue conditioning using the 'dynamic compression technique'
Number of subjects: 20

Group type: COMPARATOR
Intervention: No provisional phase
Number of subjects: 20
Study: 29354969

Group type: EXPERIMENTAL
Intervention: Touching-periosteum needling technique and rehabilitation training
Number of subjects: 106

Group type: COMPARATOR
Intervention: Routine acupuncture and rehabilitation training
Number of subjects: 106
Study: 25925019

Group type: EXPERIMENTAL
Intervention: Upper thoracic manipulation (single session administered to the T1 vertebral area)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham manipulation (placebo)
Number of subjects: 32
Study: 23910205

Group type: EXPERIMENTAL
Intervention: Modified transpalatal arch supported by 2 midpalatal miniscrews
Number of subjects: 51

Group type: COMPARATOR
Intervention: High-pull headgear
Number of subjects: 51
Study: 21590643

Group type: EXPERIMENTAL
Intervention: Lentils (LGI)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Potatoes (HGI)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 18638631

Group type: EXPERIMENTAL
Intervention: Desonide foam 0.05%
Number of subjects: 75

Group type: COMPARATOR
Intervention: Vehicle foam (control)
Number of subjects: 75
Study: 16434864

Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg b.i.d.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ranitidine 300 mg b.i.d.
Number of subjects: 110
Study: 12576428

Group type: EXPERIMENTAL
Intervention: Imatinib (400 or 600 mg/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Clindamycin (CLI)
Number of subjects: 19
Study: 11314831

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (1 microg/kg), midazolam (0.05 to 0.075 mg/kg), and propofol (10 to 20 mg boluses as required)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Sevoflurane in 67% nitrous oxide
Number of subjects: 69
Study: 9173635

Group type: EXPERIMENTAL
Intervention: Community psychiatric treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control district (no community psychiatric treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schizophrenic patients
Number of subjects: 0
Study: 7892802

Group type: EXPERIMENTAL
Intervention: PREP for Effective Family Living Program (treatment group)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Prenatal course without PREP program (comparison group)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No attendance to either prenatal course or PREP program (comparison group)
Number of subjects: 9
Study: 3295380

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin treatment at a dose of 164.50 +/- 24.55 mg/kg body weight
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin treatment at a dose of 359.65 +/- 58.62 mg/kg body weight
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin treatment
Number of subjects: 20
Study: 2285464

Group type: COMPARATOR
Intervention: ORS‐90 (oral rehydration solution recommended by WHO)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: ORS‐60 (60 mmol/L sodium and 90 mmol/L glucose)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Both ORS‐90 and ORS‐60
Number of subjects: 186
Study: 16800

Group type: EXPERIMENTAL
Intervention: Antidepressant 1
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antidepressant 2
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antidepressant 3
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antidepressant 4
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antidepressant 5
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antidepressant 6
Number of subjects: 120
Study: 31106486

Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 27829521

Group type: EXPERIMENTAL
Intervention: Relaxed-arm (N=69)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Incremental-arm (N=74)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Infants with preoperative serum chloride < 100mmol/L
Number of subjects: 143
Study: 26077436

Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium 2% solution (40.4 mg/2 mL) BID for 7.5 days
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium 1.5% solution (19.3 mg/40 drops) QID for 7.5 days
Number of subjects: 76

Group type: COMPARATOR
Intervention: Oral diclofenac sodium 75 mg BID for 7.5 days
Number of subjects: 76
Study: 23790158

Group type: EXPERIMENTAL
Intervention: Parent ratings of adolescents’ daily behaviors associated with executive functioning (EF)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Common measure of verbal memory
Number of subjects: 132
Study: 21860559

Group type: EXPERIMENTAL
Intervention: DA-9601 60 mg three times daily
Number of subjects: 266

Group type: COMPARATOR
Intervention: Misoprostol 200 µg three times daily
Number of subjects: 266
Study: 19219495

Group type: EXPERIMENTAL
Intervention: Nasogastric tube (NG tube)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No nasogastric tube (NG tube)
Number of subjects: 0
Study: 17092740

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg oral dose
Number of subjects: 15
Study: 12842515

Group type: EXPERIMENTAL
Intervention: Starr Edwards prosthesis
Number of subjects: 267

Group type: COMPARATOR
Intervention: St. Jude prosthesis
Number of subjects: 267
Study: 10803439

Group type: EXPERIMENTAL
Intervention: Patients with stable CAD (n=54)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Patients with unstable CAD (n=56)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Controls (n=49)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Patients with unstable angina (n=49)
Number of subjects: 110
Study: 8888028

Group type: EXPERIMENTAL
Intervention: Urokinase (420,000 units over two days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sodium ozagrel (160 mg/day for two weeks)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sodium ozagrel
Number of subjects: 34
Study: 1889274

Group type: EXPERIMENTAL
Intervention: EnsurePlus HN (E)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pulmocare (P)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Noncaloric placebo (C)
Number of subjects: 12
Study: 6220603

Group type: EXPERIMENTAL
Intervention: Moxalactam (250 mg every 12 hours)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Tobramycin (1.0 mg/kg every eight hours)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 111

Group type: COMPARATOR
Intervention: Tobramycin
Number of subjects: 111